nach oben

Pediatric Drugs

Erschienen in:

01.08.2003 | Therapy In Practice

New and Emerging Therapies for Short Bowel Syndrome in Children

verfasst von: Dr Jon A. Vanderhoof, Rosemary J. Young, Jon S. Thompson

Erschienen in: Pediatric Drugs | Ausgabe 8/2003

Einloggen, um Zugang zu erhalten

Abstract

This review provides an overview of traditional as well as emerging therapies useful in the management of pediatric short bowel syndrome. Pediatric short bowel syndrome is relatively uncommon; however, when it does occur, it presents a unique challenge to medical care providers. The use of parenteral and enterai nutrition to maximize growth and enhance intestinal adaptation so as to increase absorptive surface area has been the primary focus of therapy. In recent years, the advent of pharmacologic advances, including the use of antibacterial drugs, anti-motility drugs and hormonal therapies, has had a significant impact on this condition. At times, surgery may be indicated for dealing with complications, or providing alternative therapy such as transplantation. With ongoing research, it is likely that improved pharmacologic therapy will be available for enhanced intestinal adaptation, control of gut motility, treatment of small bowel bacterial overgrowth, and treatment of rejection following small intestinal transplantation.

Vanderhoof JA. Short bowel syndrome and intestinal adaptation. In: Walker WA, Durie PR, Hamilton JR, et al., editors. Pediatric gastrointestinal disease. 3rd ed. Hamilton: BC Decker, 2000: 583–602

Nightingale JMD, Kamm MA, van der Sijp JRM, et al. Gastrointestinal hormones in short bowel syndrome: peptide YY may be the “colonic brake” to gastric emptying. Gut 1996; 39: 267–72PubMedCrossRef

Vanderhoof JA, Young RJ. Short bowel syndrome. In: Lifschitz CH, editor. Pediatric gastroenterology and nutrition in clinical practice. New York: Marcel Dekker, 2002: 701–23

Andorsky DJ, Lund DP, Lillehei CW, et al. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr 2001; 139(1): 5–7CrossRef

Vanderhoof JA, Young RJ. Enteral nutrition in short bowel syndrome. Semin Pediatr Surg 2001; 10(2): 65–71PubMedCrossRef

Bines J, Francis D, Hill D. Reducing parenteral requirement in children with short bowel syndrome: impact of an amino acid-based complete infant formula. J Pediatr Gastroenterol Nutr 1998; 27(5): 614–6CrossRef

Vanderhoof JA. Short bowel syndrome: parenteral nutrition versus intestinal transplantation. Ped Nutr ISPEN 1999; 1(1): 8–15

Vanderhoof JA. Short bowel syndrome. In: Walker WA, Watkins JB, editors. Nutrition in pediatrics. 2nd ed. Hamilton: BC Decker, 1996: 609–18

Kelly DA. Liver complications of pediatric parenteral nutrition: epidemiology. Nutrition 1998; 14(1): 153–7PubMedCrossRef

10.

Vanderhoof JA, Langnas AN. Short bowel syndrome in children and adults. Gastroenterology 1997; 113: 1767–78PubMedCrossRef

11.

Vanderhoof JA, Park JH, Herrington MK, et al. Effects of dietary menhaden oil on mucosal adaptation after small bowel resection in rats. Gastroenterology 1994; 106(1): 94–9PubMed

12.

Byrne TA, Persinger RL, Young LS, et al. A new treatment for patients with short bowel syndrome: growth hormone, glutamine, and a modified diet. Ann Surg 1995; 222(3): 243–54PubMedCrossRef

13.

Scolapio JS, Camilleri M, Fleming CR, et al. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology 1997; 113(4): 1402–5CrossRef

14.

Szkudlarek J, Jeppesen PB, Mortensen PB. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomized, double-blind, placebo controlled study. Gut 2000; 47(2): 199–205PubMedCrossRef

15.

Jeppesen PB, Szkudlarek J, Hoy CE, et al. Effect of high-dose growth hormone and glutamine on body composition, urine creatinine excretion, fatty acid absorption and essential fatty acids status in short bowel patients: a randomized, double-blind, placebo-controlled study. Scand J Gastroenterol 2001; 36(1): 48–54PubMedCrossRef

16.

Vanderhoof JA, Kollman KA, Griffin S, et al. Growth hormone and glutamine do not stimulate intestinal adaptation following massive small bowel resection in the rat. J Pediatr Gastroenterol Nutr 1997; 25: 327–31PubMedCrossRef

17.

Ljungmann K, Grofte T, Kissmeyer-Nielsen P, et al. GH decreases hepatic amino acid degradation after small bowel resection in rats without enhancing bowel adaptation. Am J Physiol Gastrointest Liver Physiol 2000; 279(4): G700–6PubMed

18.

Gu Y, Wu ZH. The anabolic effects of recombinant human growth hormone and glutamine on parenterally fed, short bowel rats. World J Gastroenterol 2002; 8(4): 752–7PubMed

19.

Waitzberg DL, Cukier C, Mucerino DR, et al. Small bowel adaptation with growth hormone and glutamine after massive resection of rat’s small bowel. Nutr Hosp 1999; 14(2): 81–90PubMed

20.

Stern LE, Erwin CR, Falcone RA, et al. CDNA microarray analysis of adapting bowel after intestinal resection. J Pediatr Surg 2001; 36(1): 190–5PubMedCrossRef

21.

Thompson JS. Epidermal growth factor and the short bowel syndrome. J Parenter Enteral Nutr 1999; 23: S113–6CrossRef

22.

Jeppesen PB, Harmann B, Thulesen J, et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short bowel patients with no colon. Gastroenterology 2001; 120: 806–15PubMedCrossRef

23.

Nehra V, Camilleri M, Burton D, et al. An open trial of octreotide long-acting release in the management of short bowel syndrome. Am J Gastroenterol 2001; 96: 1494–8PubMedCrossRef

24.

Afaran M, Janson ET, Gelerman G, et al. Novel long-acting somatostatin analog with endocrine selectivity: potent suppression of growth hormone but not of insulin. Endocrinology 2001; 142(1): 477–86CrossRef

25.

Sondheimer JM, Asturias E, Cadnapaphornchai M. Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 1998; 27(2): 131–7PubMedCrossRef

26.

Teitelbaum DH, Tracy T. Parenteral nutrition-associated cholestasis. Semin Pediatr Surg 2001; 10(2): 72–80PubMedCrossRef

27.

Taylor SF, Sondheimer JM, Sokol RJ, et al. Noninfectious colitis associated with short gut syndrome in infants. J Pediatr 1991; 119: 24–8PubMedCrossRef

28.

Vanderhoof JA, Young RJ, Murray N, et al. Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome. J Pediatr Gastroenterol Nutr 1998; 27: 155–60PubMedCrossRef

29.

Warner BW, Ziegler MM. Management of the short bowel syndrome in the pediatric population. Pediatr Clin North Am 1993; 40(6): 1335–50PubMed

30.

Thompson JS, Langnas AN, Pinch LW, et al. Surgical approach to the short bowel syndrome: experience in a population of 160 patients. Ann Surg 1995; 222: 600–7PubMed

31.

Thompson JS. Surgical approach to the short bowel syndrome: procedures to slow intestinal transit. Eur J Pediatr Surg 1999; 9: 263–6PubMedCrossRef

32.

Bianchi A. Intestinal lengthening: an experimental and clinical review. J R Soc Med 1984; 77: 35–41PubMed

33.

Thompson JS, Pinch LW, Young R, et al. Long-term outcome of intestinal lengthening. Transplant Proc 2000; 32: 1242–3PubMedCrossRef

34.

Georgeson K, Halpin D, Figuero R, et al. Sequential intestinal lengthening procedures for refractory short bowel syndrome. J Pediatr Surg 1994; 29: 316–21PubMedCrossRef

35.

Kimura K, Soper RT. A new bowel elongation technique for the short bowel syndrome using the isolated segment Iowa models. J Pediatr Surg 1993; 28: 792–4PubMedCrossRef

36.

Langnas AN. Human intestinal transplantation an effective treatment of intestinal failure. 6th International Symposium on Small Bowel Transplantation; 1999 Oct 8; Omaha (NE)

37.

Goulet O, Revillon Y, Jan D, et al. Which patients need small bowel transplantation for neonatal short bowel syndrome? Transplant Proc 1991; 24(3): 1058–9

38.

Kaufman SS. Small bowel transplantation: selection criteria, operative techniques, advances in specific immunosuppression, prognosis. Curr Opin Pediatr 2001; 13(5): 425–8PubMedCrossRef

39.

Candusso M, Faraguna D, Sperli D, et al. Outcome and quality of life in paediatric home parenteral nutrition. Curr Opin Clin Nutr Metab Care 2002; 5(3): 309–14PubMedCrossRef

40.

Sondheimer JM, Cadnapaphornshai M, Sontag M, et al. Predicting the duration of dependence on parenteral nutrition after neonatal intestinal resection. J Pediatr 1998; 132(1): 80–4PubMedCrossRef

Titel: New and Emerging Therapies for Short Bowel Syndrome in Children
verfasst von: Dr Jon A. Vanderhoof
Rosemary J. Young
Jon S. Thompson
Publikationsdatum: 01.08.2003
Verlag: Springer International Publishing
Erschienen in: Pediatric Drugs / Ausgabe 8/2003
Print ISSN: 1174-5878
Elektronische ISSN: 1179-2019
DOI: https://doi.org/10.2165/00148581-200305080-00003

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

New and Emerging Therapies for Short Bowel Syndrome in Children

Abstract

Neu im Fachgebiet Pädiatrie

Ähnliche Überlebensraten nach Reanimation während des Transports bzw. vor Ort

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Bei Amblyopie früher abkleben als bisher empfohlen?

Update Pädiatrie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2003

Oxcarbazepine

Pediatric Molluscum Contagiosum

Comparative Efficacy of Two Once Daily Methylphenidate Formulations (Ritalin® LA™1 and Concerta®) and Placebo in Children with Attention Deficit Hyperactivity Disorder Across the School Day

Childhood Ependymoma

Coronary Artery Vasculopathy in Pediatric Cardiac Transplant Patients

Neu im Fachgebiet Pädiatrie

Ähnliche Überlebensraten nach Reanimation während des Transports bzw. vor Ort

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Bei Amblyopie früher abkleben als bisher empfohlen?

Update Pädiatrie